Notify me when venBio Partners LLC files a new 13F portfolio report.
⭐ Subscribe ⭐| Quarter | Holdings | Value $ | Bought | Sold | Net | Top Holdings | Form Type | Date Filed |
|---|---|---|---|---|---|---|---|---|
| Q3 2025 | 6 | $176M | +$8.73M | $0 | +$8.73M | PHVS, ALMS, ALXO, HRMY, LYEL | 13F-HR | 11/14/2025, 04:22 PM |
| Q2 2025 | 6 | $115M | +$9.68M | -$13.3M | -$3.62M | PHVS, HRMY, ALMS, LYEL, ALXO | 13F-HR | 8/14/2025, 04:15 PM |
| Q1 2025 | 7 | $124M | $0 | -$2.62M | -$2.62M | PHVS, ALMS, HRMY, SLRN, ALXO | 13F-HR | 5/15/2025, 04:18 PM |
| Q4 2024 | 7 | $171M | +$4.55M | -$3.04M | +$1.5M | PHVS, ALMS, HRMY, ALXO, ARTV | 13F-HR | 2/14/2025, 04:26 PM |
| Q3 2024 | 6 | $194M | +$23.5M | -$23.4M | +$79K | PHVS, ALMS, HRMY, ARTV, SLRN | 13F-HR | 11/14/2024, 04:20 PM |
| Q2 2024 | 6 | $232M | +$37.6M | -$707K | +$36.9M | PHVS, ALXO, ALMS, HRMY, SLRN | 13F-HR | 8/14/2024, 04:12 PM |
| Q1 2024 | 5 | $282M | $0 | -$337M | -$337M | ALXO, PHVS, HRMY, SLRN, ELEV | 13F-HR | 5/15/2024, 04:35 PM |
| Q4 2023 | 7 | $667M | +$18.4M | -$26.4M | -$7.99M | RYZB, ALXO, PHVS, HRMY, SLRN | 13F-HR | 2/14/2024, 04:41 PM |
| Q3 2023 | 8 | $353M | +$126M | -$48.4K | +$126M | RYZB, PHVS, ALXO, SLRN, HRMY | 13F-HR | 11/14/2023, 04:38 PM |
| Q2 2023 | 7 | $276M | +$112M | -$61.5M | +$50.8M | SLRN, ALXO, PHVS, HRMY, VTYX | 13F-HR | 8/14/2023, 04:32 PM |
| Q1 2023 | 6 | $180M | $0 | -$43.8M | -$43.8M | VTYX, ALXO, HRMY, PHVS, IMPLQ | 13F-HR | 5/15/2023, 04:44 PM |
| Q4 2022 | 7 | $323M | $0 | -$94.3M | -$94.3M | VTYX, ALXO, HRMY, PHVS, IMPLQ | 13F-HR | 2/14/2023, 05:10 PM |
| Q3 2022 | 8 | $432M | $0 | -$77.9M | -$77.9M | VTYX, ALXO, CINC, HRMY, AKRO | 13F-HR | 11/14/2022, 04:36 PM |
| Q2 2022 | 9 | $351M | +$3.1M | -$17.5M | -$14.4M | ALXO, HRMY, VTYX, PHVS, CINC | 13F-HR | 8/15/2022, 04:59 PM |
| Q1 2022 | 10 | $451M | +$34.7M | -$58.2M | -$23.4M | ALXO, HRMY, VTYX, PHVS, CINC | 13F-HR | 5/16/2022, 04:48 PM |
| Q4 2021 | 9 | $555M | +$99.5M | -$24.9M | +$74.7M | ALXO, HRMY, VTYX, AKRO, PHVS | 13F-HR | 2/14/2022, 05:06 PM |
| Q3 2021 | 9 | $1B | $0 | -$42.9M | -$42.9M | ALXO, HRMY, AKRO, PHVS, IMPLQ | 13F-HR | 11/15/2021, 04:23 PM |
| Q2 2021 | 10 | $847M | +$59.8M | -$11M | +$48.8M | ALXO, HRMY, AKRO, PHVS, ELEV | 13F-HR | 8/16/2021, 04:43 PM |
| Q1 2021 | 8 | $1.05B | +$64.4M | -$311K | +$64.1M | ALXO, HRMY, AKRO, PHVS, CMPI | 13F-HR | 5/17/2021, 04:22 PM |
| Q4 2020 | 7 | $1.13B | $0 | -$8.63M | -$8.63M | ALXO, HRMY, AKRO, CMPI, APLS | 13F-HR | 2/16/2021, 04:46 PM |
| Q3 2020 | 8 | $658M | +$558M | -$32.5M | +$526M | ALXO, HRMY, AKRO, CMPI, MTCR | 13F-HR | 11/16/2020, 04:26 PM |
| Q2 2020 | 4 | $120M | $0 | -$21.2M | -$21.2M | AKRO, DTIL, APLS, VRNA | 13F-HR | 8/14/2020, 04:49 PM |
| Q1 2020 | 6 | $117M | $0 | -$57.9M | -$57.9M | AKRO, DTIL, APLS, TPTX, MNLO | 13F-HR | 5/15/2020, 04:16 PM |
| Q4 2019 | 6 | $233M | $0 | -$39.7M | -$39.7M | AKRO, DTIL, TPTX, APLS, MNLO | Restatement | 5/20/2020, 05:23 PM |
| Q3 2019 | 6 | $211M | $0 | $0 | AKRO, TPTX, DTIL, APLS, MNLO | Restatement | 5/20/2020, 05:22 PM | |
| Q2 2019 | 6 | $225M | +$130M | -$13.3M | +$117M | AKRO, DTIL, TPTX, APLS, MNLO | Restatement | 5/20/2020, 05:22 PM |
| Q1 2019 | 4 | $123M | +$76.6M | -$5.15M | +$71.4M | DTIL, APLS, MNLO, VRNA | Restatement | 5/20/2020, 05:21 PM |
| Q4 2018 | 3 | $38.1M | $0 | $0 | APLS, VRNA, MNLO | 13F-HR | 5/26/2020, 03:56 PM |